Nicholas J. White

发表

Statistical Power Calculations for Mixed Pharmacokinetic Study Designs Using a Population Approach

Nicholas P. J. Day, Julie A. Simpson, Frank Kloprogge, 2014, The AAPS Journal.

Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey

Anne Mills, Mike English, Peter Kremsner, 2011, PloS one.

High-Throughput Ultrasensitive Molecular Techniques for Quantifying Low-Density Malaria Parasitemias

Nicholas P. J. Day, Nicholas J. White, Francois Nosten, 2014, Journal of Clinical Microbiology.

Activities of Artesunate and Primaquine against Asexual- and Sexual-Stage Parasites in Falciparum Malaria

Nicholas J. White, Sasithon Pukrittayakamee, N. White, 2004, Antimicrobial Agents and Chemotherapy.

Drug resistance in malaria

Nicholas J. White, 1998 .

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.

Ogobara K. Doumbo, Simon I. Hay, Peter W. Gething, 2015 .

Timing of Enteral Feeding in Cerebral Malaria in Resource-Poor Settings: A Randomized Trial

Richard J. Maude, Nicholas P. J. Day, Abu Sayeed, 2011, PloS one.

No Evidence for Spread of Plasmodium falciparum Artemisinin Resistance to Savannakhet Province, Southern Laos

Mayfong Mayxay, Paul N. Newton, Nicholas J. White, 2012, The American journal of tropical medicine and hygiene.

Intrahost modeling of artemisinin resistance in Plasmodium falciparum

Richard J. Maude, Nicholas P. J. Day, François Nosten, 2010, Proceedings of the National Academy of Sciences.

Optimising Strategies for Plasmodium falciparum Malaria Elimination in Cambodia: Primaquine, Mass Drug Administration and Artemisinin Resistance

Richard J. Maude, Nicholas J. White, Lisa J. White, 2012, PloS one.

Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease

John Whitehead, Trudie Lang, Nicholas P. J. Day, 2015, PLoS medicine.

Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18

Kim Rutherford, Anders Krogh, Stephen D. Bentley, 2001, Nature.

The spectrum of retinopathy in adults with Plasmodium falciparum malaria

Richard J. Maude, Nicholas J. White, Amir Hossain, 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

The murine cerebral malaria phenomenon

Nicholas J. White, Arjen M. Dondorp, N. Day, 2010, Trends in parasitology.

Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza

Nicholas J. White, N. V. Trung, Nguyen Duc Hien, 2008, PloS one.

Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria

Richard J. Maude, Nicholas P. J. Day, Nicholas J. White, 2017, PloS one.

The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Benedikt Ley, Binh Q. Tran, Guy Thwaites, 2019, BMC Medicine.

Spiroindolone KAE609 for falciparum and vivax malaria.

Baldur P Magnusson, Baldur Magnusson, François Nosten, 2014, The New England journal of medicine.

The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers

Paul N. Newton, Nicholas J. White, P. Newton, 2005, PLoS Medicine.

Development of temporal modelling for forecasting and prediction of malaria infections using time-series and ARIMAX analyses: A case study in endemic districts of Bhutan

Jaranit Kaewkungwal, Saranath Lawpoolsri, Pratap Singhasivanon, 2010, Malaria Journal.

Evolution and expansion of multidrug resistant malaria in Southeast Asia: a genomic epidemiology study

Richard J. Maude, Nicholas P. J. Day, Mehul Dhorda, 2019 .

A Phase III, Randomized, Non-Inferiority Trial to Assess the Efficacy and Safety of Dihydroartemisinin-Piperaquine in Comparison with Artesunate-Mefloquine in Patients with Uncomplicated Plasmodium falciparum Malaria in Southern Laos

Mayfong Mayxay, Paul N. Newton, Nicholas J. White, 2010, The American journal of tropical medicine and hygiene.

Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs

May Ho, Thomas E. Wellems, Liwang Cui, 2010, Nature Genetics.

A Research Agenda for Malaria Eradication: Drugs

Yongyuth Yuthavong, Rhoel R. Dinglasan, Robert E. Sinden, 2011, PLoS medicine.

Pharmacokinetic Properties of Artemether, Dihydroartemisinin, Lumefantrine, and Quinine in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria in Uganda

Mehul Dhorda, Frank Kloprogge, Nicholas J. White, 2013, Antimicrobial Agents and Chemotherapy.

Mefloquine Pharmacokinetic-Pharmacodynamic Models: Implications for Dosing and Resistance

Leon Aarons, Dennis E. Kyle, Julie A. Simpson, 2000, Antimicrobial Agents and Chemotherapy.

Randomized Controlled Trial of Levamisole Hydrochloride as Adjunctive Therapy in Severe Falciparum Malaria With High Parasitemia

Richard J. Maude, Faridul Islam, Kamolrat Silamut, 2013, The Journal of infectious diseases.

Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment

Stephane Proux, Pratap Singhasivanon, François Nosten, 2009, PloS one.

Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei

Nicholas J. White, Sharon J. Peacock, N. Day, 2006, Nature Reviews Microbiology.

Journal of Pharmaceutical and Biomedical Analysis Development of Nirs Method for Quality Control of Drug Combination Artesunate–azithromycin for the Treatment of Severe Malaria

Nicholas J. White, P. Olliaro, N. White, 2022 .